Red Line is a lipolytic injectable that combines deoxycholic acid (DCA) with L-carnitine and vitamin B12, sold in 10 ml vials packed in boxes of ten. The manufacturer frames it as a “double effect” blend. This is a medical procedure for a licensed professional, never a DIY shortcut.

What is Red Line, and what is in the blend?

Red Line is a fat-dissolving injectable built around three ingredients. The main active is deoxycholic acid, a bile acid your body makes to emulsify dietary fat, which the maker says breaks down fat-cell walls. The blend then adds L-carnitine, a compound that helps the body shuttle fatty acids into cells to be burned for energy, and vitamin B12, which the maker links to circulation support.

The manufacturer describes this as a “double effect”: DCA disrupts fat-cell membranes (with a claimed collagen and elasticity benefit), while L-carnitine helps the body metabolize the released fatty acids. The product ships in 10 ml vials, boxed in tens. Read the combined-effect framing as the manufacturer’s claim, not proven fact.

Log Notes. This page explains what Red Line is and the roles its maker assigns each ingredient. It gives no doses, volumes, injection sites, depths, session counts, or technique. Those belong to a licensed professional and the official guide, not a blog. Nothing here is medical advice, and injectable lipolysis is never a do-it-yourself procedure.

Is Red Line FDA-approved, and what are the risks?

This is the honest center of the post. Deoxycholic acid is the only fat-dissolving ingredient that holds FDA approval, sold as Kybella, and only for fat under the chin (submental fat). Adding L-carnitine and B12 does not extend that clearance. Korean blends like Red Line are generally not FDA-approved, so any use sits outside the narrow approval that exists.

The regulator is direct about the broader category. The FDA warns that fat-dissolving injections that are not FDA-approved can be harmful and that it cannot confirm their safety, quality, or effectiveness. Combining ingredients can also add complexity rather than safety. Injectable lipolysis carries real risks, swelling, bruising, nodules, nerve injury, and uneven results among them, so this stays a medical decision for a qualified professional.

What should you expect, and what is worth tracking?

Gradual change and a careful record. Like other lipolytics, Red Line is discussed as a course rather than a single visit, and any reduction in a treated area shows up slowly over weeks. That timeline rewards a dated log and punishes memory, which tends to flatter recent results.

This is exactly where Dosefi fits a methodical routine. If you pursue Red Line with a licensed professional, you log each session with its date and a photo, set a reminder for the review window your provider gives you, and self-rate the treated area so trends build over the following weeks. A log never makes a procedure safe; it just keeps your own history honest and organized.

Because these injectables overlap so much, comparing them helps you ask sharper questions. Our notes on the gentler-positioned DCA brand Kabelline and the high-capacity deoxycholate blend Sedy Line show how the same bile acid gets packaged differently.

A grounded takeaway

Red Line is a deoxycholic acid lipolytic blended with L-carnitine and B12, sold in 10 ml vials and marketed as a double-effect formula. The honest bottom line is regulatory: deoxycholic acid is FDA-approved only for under-chin fat as Kybella, blends like this are generally not approved, and the FDA warns non-approved fat-dissolving injections can be harmful. Route candidacy and the procedure to a licensed professional. The guide is attached for reference only.

Sources